PharmaLex Spain
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
PharmaLex Spain - overview
Established
2001
Location
Zaragoza, -, Spain
Primary Industry
Pharmaceuticals
About
PharmaLex Spain specializes in offering regulatory and consultancy services tailored for the pharmaceutical, biotech, and medical device sectors, helping clients navigate complex compliance and product lifecycle challenges. Founded in 2001 in Zaragoza, Spain, PharmaLex Spain provides a broad range of consulting services to the pharmaceutical and biotech industries. The company has engaged in one notable deal in its history, with the most recent transaction occurring on July 28, 2015, when YES Pharmaceutical Development Services GmbH acquired ActioMed Farmacovigilancia SL. The details of this acquisition were not disclosed.
PharmaLex specializes in providing a comprehensive suite of services tailored for the pharmaceutical, biotech, and medical device industries. Their core offerings include strategic and scientific consultancy, integrated product development, and optimal patient access solutions. These services address critical regulatory challenges and support companies in navigating product lifecycles from development through commercialization. PharmaLex serves a diverse clientele globally, including numerous small to medium-sized enterprises and nine out of ten leading pharmaceutical companies across markets such as North America, Europe, and Asia-Pacific.
In 2024, PharmaLex reported a revenue of USD 23. 24 mn and an EBITDA of USD 1. 43 mn, demonstrating a stable financial performance through its consultancy-based service model. PharmaLex aims to enhance its service offerings and expand into new markets by developing innovative solutions tailored for evolving industry needs.
The company plans to focus on expanding its presence in the Asia-Pacific region by 2025, leveraging recent funding to support these initiatives. The acquisition of ActioMed Farmacovigilancia SL in July 2015 is seen as a part of this strategy to strengthen their market position and broaden their service capabilities.
Current Investors
YES Pharmaceutical Development Services GmbH
Primary Industry
Pharmaceuticals
Sub Industries
Consulting Services, Healthcare, Pharmaceutical Research & Development
Website
www.pharmalex.com
Company Stage
Add-on
Total Amount Raised
Subscriber access only
PharmaLex Spain - timeline of key events
PharmaLex Spain - financials
| Fiscal Year Ended | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Sep 30, 2023 | Sep 30, 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | - | - | - | 5,242,953.9 | 8,102,705.9 | 8,409,729 | 10,210,652.4 | - | - | - |
| % Revenue Growth (YoY) | - | - | - | - | 54.5% | 3.8% | 21.4% | - | - | - |
| EBITDA (USD) | (4,674.4) | (259,936.6) | (4,737.1) | 834,304.1 | 1,596,831.6 | 1,535,407.7 | 1,687,283 | - | - | - |
| Operating Income (USD) | (4,674.4) | (259,936.6) | (4,737.1) | 570,165.9 | 1,112,591.6 | 1,051,560.7 | 1,207,673 | - | - | - |
| Operating Margin | - | - | - | 10.9% | 13.7% | 12.5% | 11.8% | - | - | - |
| % EBITDA Margin | - | - | - | 15.9% | 19.7% | 18.3% | 16.5% | - | - | - |
| NET Income (USD) | (33,826.1) | 351,166.2 | 1,163,116.9 | 607,312.5 | 829,853 | 723,949.2 | 1,098,815.9 | - | - | - |
| % Net Margin | - | - | - | 11.6% | 10.2% | 8.6% | 10.8% | - | - | - |
PharmaLex Spain - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Completed | PharmaLex Spain | - |
Displaying 1 - 1 of 1
PharmaLex Spain - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.